We have come up with a way to reduce the problems in pain medicine, with our genetic testing.
Irvine, CA (PRWEB) February 03, 2015
Proove Biosciences, a commercial and research leader in Personalized Medicine, participated in the Personalized Medicine World Conference in Silicon Valley January 26-28, 2015. CEO and Founder, Brian Meshkin spoke on “The Emerging FIeld of Genetics and Personalized Medicine”. The conference was co-hosted by Stanford Health Care and Oracle Health Sciences and brought together key opinion leaders and stakeholders in the personalized medicine field.
“A doctor’s ability to identify patients who will misuse opioids is the simple flip of a coin, a 50% chance. We have come up with a way to reduce the problems in pain medicine with our genetic testing increasing that percentage to over 93%.”, stated Proove Biosciences, founder and CEO, Brian Meshkin.
Brian’s presentation continued explaining Proove’s mission to provide the proof to improve health care decisions in personalized medicine. Proove has become the leader in this industry with three pain medicine tests in market and over two hundred million dollars in billings during 2014. Proove invests twenty percent of earnings back into the Research and Development department, having the world’s largest practice based evidence database in personalized pain medicine with over 70,000 subjects, as well as, thirty plus additional tests in the pipeline to be released in 2015.
About Proove Biosciences
Our Mission is to Change the Future of Medicine. Proove is the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could’ve ever prescribed medications without knowing how a patient would respond. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of personalized pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve outcomes – both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).